| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 09/29/2011 | US20110237811 Stabilized steroid composition and method for its preparation |
| 08/23/2011 | US8003629 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/10/2011 | CN102146113A Method for synthesizing 16 alpha-hydroxy prednisolone |
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 07/27/2011 | EP2348031A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/27/2011 | EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/26/2011 | US7985744 Vitamin D derivatives |
| 07/21/2011 | WO2011087441A1 A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties |
| 07/21/2011 | CA2786330A1 A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties |
| 07/20/2011 | CN101161679B Method for preparing dexamethasone artificial antigen |
| 07/06/2011 | CN101418029B Method for synthesizing methylprednisolone |
| 07/05/2011 | CA2448296C Methods of making 21-[4'-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 06/16/2011 | WO2011019821A3 METHOD FOR MAKING 3α-HYDROXY, 3β- METHYL-5α-PREGNAN-20-ONE (GANAXOLONE) |
| 06/14/2011 | CA2512987C 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 06/02/2011 | US20110130376 New no releasing steroids derivatives |
| 06/02/2011 | US20110130375 New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 06/01/2011 | CN102079768A Preparation method of prednisolone hydrate |
| 06/01/2011 | CN102079767A Preparation method of Halometasone monohydrate |
| 05/19/2011 | US20110118228 Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof |
| 05/19/2011 | US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases |
| 05/18/2011 | EP1295871B1 Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond |
| 05/18/2011 | CN101537344B Monolithic column, preparation method and application thereof |
| 05/18/2011 | CN101397318B Technique for refining fluocinonide 9 fluorine |
| 05/17/2011 | CA2411409C Vitamin d derivatives |
| 05/10/2011 | CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides |
| 05/04/2011 | CN102040649A Synthesis process for preparing steride 6-fluorine with NFOBS (N-Fluoro-Ortho-Benzenedisulfonimide) or NBSI fluorinating agent |
| 05/04/2011 | CN102040648A Preparation method of deta9(11) steroidal compound |
| 05/04/2011 | CN102040647A Synthesis process for preparing steride 6-fluorine with triazine alizarin complexone |
| 05/04/2011 | CN102040646A Synthetic process for preparing 6alpha-fluoro steroids by using NFTh fluorinating agent |
| 05/04/2011 | CN102040645A Synthetic process for preparing 6alpha-fluoro steroids by using NFOBS or NBSI fluorinating agent |
| 05/04/2011 | CN101397322B Preparation of desoximetasone |
| 05/04/2011 | CN101168555B Preparation of medicine and derivative thereof |
| 04/28/2011 | US20110098260 Steroid Compounds and Formulations |
| 04/21/2011 | US20110092472 Enzymatic process for obtaining 17 alpha- monoesters of cortexolone and/or its 9,11- dehydroderivatives |
| 04/06/2011 | CN101125877B Method for preparing methylprednisolone acetate |
| 03/23/2011 | CN101987859A Aryl ammonia sulphonyl sulphonate derivative of glucocorticoid |
| 02/17/2011 | WO2011019821A2 METHOD FOR MAKING 3α-HYDROXY, 3β- METHYL-5α-PREGNAN-20-ONE (GANAXOLONE) |
| 02/17/2011 | CA2769820A1 Method for making 3.alpha.-hydroxy, 3.beta.- methyl-5.alpha.-pregnan-20-one (ganaxolone) |
| 02/08/2011 | US7884222 Process for the production of tibolone |
| 02/01/2011 | US7879833 comprising a fixed combination of active compounds consisting of the active compound ciclesonide or an epimer thereof and the active compound R,R-formoterol or a salt, in an administration form suitable for inhalative administration by means of a powder inhaler; treatment of bronchitis, asthma |
| 01/19/2011 | EP2273994A2 Solid state forms of a pharmaceutical |
| 01/19/2011 | CN101952238A Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 01/12/2011 | CN101942002A Refining technology for steroid 21-position ester |
| 01/05/2011 | CN101003561B Polyhydroxyl steroid compound, synthetic method, and application |
| 01/04/2011 | CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them |
| 12/29/2010 | CN101928318A Preparation of fluorine-containing steroid hormone |
| 12/15/2010 | CN101161681B Method for preparing double-flumethasone artificial antigen |
| 12/08/2010 | EP2258363A1 Compositions for treatment of cancers |
| 12/08/2010 | EP1007017B2 Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof |
| 12/08/2010 | CN101200484B Production technique of steroid ring-opening product |
| 12/02/2010 | WO2010136940A1 Novel glucocorticoid receptor agonists |
| 12/02/2010 | CA2760284A1 Novel glucocorticoid receptor agonists |
| 11/30/2010 | US7842680 Diene and triene compounds and formulations |
| 11/24/2010 | CN101891797A Method for preparing sterides compound 17-alpha ester |
| 11/24/2010 | CN101891789A Prednisolone hydrate production process |
| 11/11/2010 | US20100286107 Oligomer-Corticosteroid Conjugates |
| 11/09/2010 | US7829555 noncytotoxic bioreductive drug conjugates, used for targeting a therapeutic agent to a site of hypoxia and/or ischemia within the human or non-human animal body, suitable for the treatment of arthritis, diabetes, atherosclerosis, stroke, sepsis, cancer, Alzheimer's, kidney, digestive or liver disease |
| 11/04/2010 | US20100278896 Solid compositions |
| 11/03/2010 | CN101875681A Synthetic method of 16alpha-hydroxy prednisonlone |
| 10/28/2010 | US20100273759 Progesterone antagonists |
| 10/13/2010 | CN101559287B Method for drying hydrocortisone sodium succinate asepsis powder |
| 10/12/2010 | US7812009 Mastitis treatment |
| 10/12/2010 | CA2457050C Prophylactic and therapeutic use of hydroxysteroids |
| 09/21/2010 | CA2569549C Heat sterilization of glucocorticosteroids |
| 09/16/2010 | US20100234334 Nitric oxide releasing steroids |
| 08/25/2010 | CN101812106A Refining method of betamethasone epoxy hydrolysate |
| 08/18/2010 | CN101805387A Methylprednisolone aceponate new crystal form and preparation method thereof |
| 08/18/2010 | CN101805386A Hydrocortisone production process based on ionic liquid |
| 08/18/2010 | CN101804061A New methylprednisolone tablets and crystal form and preparation method thereof |
| 08/12/2010 | US20100204497 Process For The Preparation of 7 alpha-Methylsteroids |
| 08/10/2010 | US7772218 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer. |
| 07/27/2010 | US7763600 Nitric ester derivatives of hormones such as progesterone, used for preventing premature labor, increasing cervical dilatation, in hormone replacement therapy, as hypeortensive agents and for treating dysmenorrhea |
| 07/27/2010 | US7763596 Antiinflamamtory agents; immunosuppressants; antiproliferative agents; treating haematology; reduced harmful side-effects |
| 07/27/2010 | CA2427569C Selective glucocorticoid receptor agonists |
| 07/21/2010 | EP2207764A2 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 07/21/2010 | CN101781349A Method for preparing hydrocortisone acetate |
| 07/20/2010 | US7759330 21-substituted progesterone derivatives as new antiprogestational agents |
| 07/06/2010 | US7749987 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 06/30/2010 | CN101759745A Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate |
| 06/30/2010 | CN101759744A Production technology method of dexamethasone21-hydroxy |
| 06/30/2010 | CN101759743A Methylprednisolone aceponate monohydrate, crystal form and preparation method thereof |
| 06/30/2010 | CN101759742A Preparation method of 16 Alpha-methyl steroidal compound |
| 06/16/2010 | CN101743316A Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 06/09/2010 | CN1978457B Method for producing 6 alpha-methylprednisolone and its derivatives |
| 06/08/2010 | US7732432 such as (11 beta ,16 beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl ethylcarbamate, having potent antiinflammatory and immunosuppressive activity and possess advantages over steroidal glucocorticoid ligands with respect to side effects, efficacy, toxicity and/or metabolism |
| 06/03/2010 | WO2010062562A1 Synthesis and use of cationic steroids for anti-inflammatory drug therapy |
| 05/26/2010 | EP2188299A2 A method for treating diabetes |
| 05/25/2010 | CA2472379C Process for the preparation of 7.alpha.-methylsteroids |
| 05/18/2010 | US7718793 Reacting 17-hydroxy-9 beta ,11 beta -epoxy-16- beta -methyl-pregna-1,4-diene-3,20-dione 21-acetate compound with a stereoselective fluorinating agent to stereoselectively form a 21-ester, 17-hydroxy 6 alpha -fluorinated compound |
| 05/06/2010 | US20100113408 21-substituted progesterone derivatives as new antiprogestational agents |
| 04/14/2010 | EP2173891A2 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 03/03/2010 | CN101659689A Methylprednisolone derivative |
| 02/18/2010 | US20100041906 Method for the precipitation of organic compounds |
| 02/09/2010 | CA2403756C Structural modification of 19-norprogesterone i: 17-.alpha.-substituted, 11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 01/21/2010 | US20100016597 Method for producing pulverized organic compound particle |
| 12/30/2009 | EP1470151B1 Process for the preparation of 7-alpha-methylsteroids |
| 12/30/2009 | CN101613392A Method for preparing hydrocortisone sodium succinate |
| 12/16/2009 | CN100569791C Preparation technique for high-purity hydrocortisone |
| 12/15/2009 | US7632826 Use of agonists of the glucocorticosteroid and/or mineralo-corticosteroid receptors, in particular corticosteroids for the treatment of addiction |
| 12/15/2009 | CA2568510C One-pot processes for preparing prednisolone derivatives |